A groundbreaking 2020 study, conducted at Tel Aviv University and Shamir Medical Center, presents a fascinating discovery: hyperbaric oxygen treatments may not only slow down, but even reverse the aging process of blood cells in healthy older adults.
The implication of this remarkable finding is that the biological age of blood cells may actually "rejuvenate" as a result of the treatments.
The Revolutionary Process:
The researchers discovered that a unique protocol of high-pressure oxygen treatments in a hyperbaric chamber positively affects two key processes related to aging and disease:
- Telomere Shortening: The ends of chromosomes, which shorten with age and contribute to aging.
Hyperbaric oxygen treatments showed an average elongation of about 20% in blood cell telomere length, with some cell types showing elongation of up to 38%. - Accumulation of Senescent Cells (Zombie Cells): These cells do not function properly and can lead to various diseases. Hyperbaric oxygen treatments led to a reduction of up to 37% in the presence of senescent cells in some cell types.
Important Caveats: This is a small study (about 30 participants), without a control group, conducted on healthy adults aged 64 and older, and measurements were performed on isolated blood cells taken from participants. The high rates (up to 38% and up to 37%) are the maximum results in certain cell types, with large variability between cell types. Therefore, headlines like "reversing aging" or "the holy grail" should be treated with caution: larger, controlled studies are needed to substantiate the findings.
The study focused on immune cells containing DNA taken from the participants' blood.
These results raise hope for similar effects on other types of cells in the body and point to the potential for expanding testing to a wide range of medical fields.
The Leading Team:
The study was led by Professor Shai Efrati, from the Sackler School of Medicine and the Sagol School of Neuroscience at Tel Aviv University, founder and director of the Sagol Center for Hyperbaric Medicine at Shamir Medical Center; and Dr. Amir Hadanny, Chief Medical Research Officer of the Sagol Center for Hyperbaric Medicine and Research at Shamir Medical Center. The clinical trial was conducted as part of a broad Israeli research program focusing on aging as a reversible condition.
Possible Implications:
- Hyperbaric oxygen treatments may constitute a therapeutic tool with the potential to slow down and perhaps even reverse some markers of aging, but this requires confirmation in further studies.
- This discovery may lead to new research directions in the field of anti-aging medicine and a potential improvement in the health and quality of life of older adults.
Additional Information:
- Hyperbaric oxygen treatments involve breathing pure oxygen at high pressure inside a hyperbaric chamber.
- These treatments are currently given for a variety of medical conditions, including sports injuries, pressure sores, and carbon monoxide poisoning.
- Further studies are needed to examine the long-term effects of hyperbaric oxygen treatments and their effects on other types of cells in the body.
.
References:
💬 Comments (0)
Be the first to comment on the article.